Catalogo dei prodotti della ricerca
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishThe SARS-CoV-2 pandemic has already reached 3,207,248 patients with more than 225,000 deaths all over the world. Colorectal cancer is the third most diagnosed cancer worldwide, and the healthcare system is struggling to manage daily activities for elective cancer surgery. This review integrates clinical, microbiological, architectural and surgical aspects to develop indications on strategies to manage colorectal cancer patients and ensure safety during the pandemic. Telephone or virtual clinics must be encouraged and phone follow-up should be implemented. Indications for surgery must be rigorous, balancing the advantage of early surgical treatment and risks of treatment delay. To decrease the occupancy rate of intensive care unit beds, elective surgical treatment should be delayed until local endemic control, according to stage of disease. Patients with SARS-CoV-2 infection should be treated only after clinical recovery, two consecutive negative oropharyngeal swabs and, if available, a negative stool sample. Before any elective oncologic procedure, a multidisciplinary oncologic team including an anaesthesiologist and an infectious disease specialist must assess every patient to evaluate the risk of infection and its impact on perioperative morbidity, mortality and oncologic prognosis. The hospital should organise to manage all elective oncologic patients in an "infection-free" area or refer them to a non-SARS-CoV-2 hospital.
SARS-CoV-2 pandemic. Implications in the management of patients with colorectal cancer / Di Marzo, Francesco; Fiori, Enrico; Sartelli, Massimo; Cennamo, Rosario; Coccolini, Federico; Catena, Fausto; Calabretto, Marianna; Riveros Cabral, Rodolfo Javier; Lombardi, Mirko; Baiocchi, Gian Luca; Cardi, Martina; Cusi, Maria Grazia; Cardi, Maurizio. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 43:4(2020), pp. 156-160.
| Titolo: | SARS-CoV-2 pandemic. Implications in the management of patients with colorectal cancer | |
| Autori: | ||
| Data di pubblicazione: | 2020 | |
| Rivista: | ||
| Citazione: | SARS-CoV-2 pandemic. Implications in the management of patients with colorectal cancer / Di Marzo, Francesco; Fiori, Enrico; Sartelli, Massimo; Cennamo, Rosario; Coccolini, Federico; Catena, Fausto; Calabretto, Marianna; Riveros Cabral, Rodolfo Javier; Lombardi, Mirko; Baiocchi, Gian Luca; Cardi, Martina; Cusi, Maria Grazia; Cardi, Maurizio. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 43:4(2020), pp. 156-160. | |
| Abstract: | The SARS-CoV-2 pandemic has already reached 3,207,248 patients with more than 225,000 deaths all over the world. Colorectal cancer is the third most diagnosed cancer worldwide, and the healthcare system is struggling to manage daily activities for elective cancer surgery. This review integrates clinical, microbiological, architectural and surgical aspects to develop indications on strategies to manage colorectal cancer patients and ensure safety during the pandemic. Telephone or virtual clinics must be encouraged and phone follow-up should be implemented. Indications for surgery must be rigorous, balancing the advantage of early surgical treatment and risks of treatment delay. To decrease the occupancy rate of intensive care unit beds, elective surgical treatment should be delayed until local endemic control, according to stage of disease. Patients with SARS-CoV-2 infection should be treated only after clinical recovery, two consecutive negative oropharyngeal swabs and, if available, a negative stool sample. Before any elective oncologic procedure, a multidisciplinary oncologic team including an anaesthesiologist and an infectious disease specialist must assess every patient to evaluate the risk of infection and its impact on perioperative morbidity, mortality and oncologic prognosis. The hospital should organise to manage all elective oncologic patients in an "infection-free" area or refer them to a non-SARS-CoV-2 hospital. | |
| Handle: | http://hdl.handle.net/11573/1457975 | |
| Appartiene alla tipologia: | 01g Articolo di rassegna (Review) |
File allegati a questo prodotto
| File | Note | Tipologia | Licenza | |
|---|---|---|---|---|
| Di-Marzo_SARSCoV2-colorectal-cancer_2020.pdf | Versione editoriale (versione pubblicata con il layout dell'editore) | Tutti i diritti riservati (All rights reserved) | Open Access Visualizza/Apri |
Copyright © 2022